flag
Insights into Essex Partnerships deployment of OxevisionDownload
Download
arrow right
cross

Latest from Oxehealth

31
March
2021
FDA grants Oxehealth Vital Signs De Novo clearance; Oxehealth launches in the US
31
March
2021

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.

09
March
2021
Oxehealth's Charlotte Wood named one of twelve innovators selected to scale across England’s NHS with support from the NHS Innovation Accelerator
08
March
2021

Oxehealth's Oxevision named one of 12 high impact innovations to join the NHS Innovation Accelerator in 2021.

24
February
2021
Oxehealth featured in the Department for International Trade's Digital Health Campaign - 'The First 100 Playbook'
24
February
2021

Oxehealth is proud to have been included in the Department for International Trade's Digital Health Campaign - 'The First 100 Playbook'.

27
January
2021
Oxehealth Wins HTN's 2020 Excellence in Remote Monitoring Award
22
January
2021

Starting off 2021 strong by scooping up HTN's "Excellence in remote monitoring" Award!

15
December
2020
Oxehealth and partners get shortlisted as finalists for FOUR HSJ Partnership Awards 2021
14
December
2020

Oxehealth is delighted to announce that, with our partners; South London and Maudsley FT, Oxford Health, Coventry and Warwickshire Partnership Trust, we have been shortlisted for FOUR separate HSJ Partnership Awards!

09
December
2020
High tech sensors enhance safety on mental health wards
08
December
2020

Innovative technology is being installed on mental health wards at Midlands Partnership NHS Foundation Trust (MPFT) as part of a programme to continuously improve patient safety

18
November
2020
Oxehealth announces new CTO
17
November
2020

Oxehealth, a global leader in vision-based patient monitoring and management systems, have this week announced the promotion of Sarah Surrall as Chief Technology Officer.

1 / 19
arrow right

Hey! We think you’re in Sweden.

Sweden

This is our site for the UK market, do you want to visit our Swedish site?
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
cross